𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of cisplatin sensitivity and accumulation by interferon α-2A in human squamous carcinoma cell lines

✍ Scribed by Vicram Gupta; Jitesh P. Jani; Erling O. Emerson; Bing H. Xu; Domenic Scalamogna; Hong Xia; Arthur Katoh; Howard A. Zaren; Shivendra V. Singh


Publisher
John Wiley and Sons
Year
1995
Tongue
French
Weight
593 KB
Volume
63
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This study was undertaken to elucidate the mechanism(s) of potentiation of cisplatin (CDDP) cytotoxicity by interferon α‐2a (IFN α‐2a) in human squamous carcinoma cell lines SCC‐25 and SCC‐4. IFN α‐2a treatment significantly increased the cytotoxicity of CDDP in both cell lines in a dose‐dependent manner. In SCC‐25 cells, the cytotoxicity of CDDP was increased by about 2‐ and 4‐fold, respectively, by treating the cells with 400 and 800 1U/ml IFN α‐2a. Sensitivity of SCC‐4 cells to CDDP was increased by about 3‐ and 7‐fold, respectively, by 400 and 800 1U/ml IFN α‐2a treatment. Drug uptake experiments revealed approximately 1.4‐ to 5‐fold higher platinum accumulation in IFN α‐2a‐treated cells as compared to respective controls. Cellular levels of glutathione (GSH) and GSH transferase, which have been suggested to be important determinants of tumor cell sensitivity to CDDP, were not altered by IFN α‐2a treatment in either of the cell lines. Northern blot analysis showed a moderate increase (about 30–40%) in the level of MT‐II~A~ mRNA by IFN α‐2a treatment in these cells. Our results suggest that IFN α‐2a‐mediated sensitization of SCC‐25 and SCC‐4 cell lines to CDDP in vitro may be due to an increase in intracellular platinum accumulation.


📜 SIMILAR VOLUMES


Hyperphosphorylation of replication prot
✍ Karoline C. Manthey; Jason G. Glanzer; Diana D. Dimitrova; Greg G. Oakley 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 3 views

## Abstract ## Background Resistance to chemotherapy is a major limitation in the treatment of head and neck squamous cell carcinomas (HNSCCs), accounting for high mortality rates in patients. Here, we investigated the role of replication protein A (RPA) in cisplatin and etoposide resistance. ##

Modulation of cis-diamminedichloroplatin
✍ Stephen C. Mann; Paul A. Andrews; Stephen B. Howell 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 807 KB

We have determined the effect of forskolin, an adenyl cy-Clare agonist, and 3-isobutyl-I-methylxanthine (IBMX), a phosphodiesterase inhibitor, on the accumulation and cytotoxicity of cisplatin (DDP) in 2008 human ovarian carcinoma cells. In DDP-sensitive 2008 cells, forskolin and IBMX caused 2. I -f

Alteration of microRNA profiles in squam
✍ Abigail I. Wald; Elizabeth E. Hoskins; Susanne I. Wells; Robert L. Ferris; Salee 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

## Abstract ## Background Human papillomavirus (HPV)‐positive cases of squamous cell carcinoma of the head and neck (SCCHN) have a much better disease outcome compared to SCCHN cases lacking HPV. Differences in microRNA (miRNA) expression may affect their clinical outcomes. ## Methods The miRNA